We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.33B
AUM Growth
+$519M
Cap. Flow
+$261M
Cap. Flow %
11.2%
Top 10 Hldgs %
31.18%
Holding
1,170
New
202
Increased
753
Reduced
172
Closed
43

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$13.4M
2
TSLA icon
Tesla
TSLA
+$13.2M
3
MSFT icon
Microsoft
MSFT
+$5.94M
4
AAPL icon
Apple
AAPL
+$5.64M
5
NVDA icon
NVIDIA
NVDA
+$5.32M

Sector Composition

Rank Sector Weight
1 Technology 39.75%
2 Healthcare 13.35%
3 Consumer Discretionary 11.99%
4 Communication Services 9.24%
5 Energy 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
226
Philip Morris
PM
$301B
$1.6M 0.07%
17,020
+2,036
+14% +$188K
UTHR icon
227
United Therapeutics
UTHR
$26.3B
$1.6M 0.07%
7,265
-493
-6% -$114K
TGTX icon
228
TG Therapeutics
TGTX
$8.58B
$1.6M 0.07%
93,489
-50,092
-35% -$582K
ALNY icon
229
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.59M 0.07%
8,332
+1,075
+15% +$183K
D icon
230
Dominion Energy
D
$62.5B
$1.59M 0.07%
33,829
-879
-3% -$39.2K
HALO icon
231
Halozyme
HALO
$9.72B
$1.59M 0.07%
42,904
-1,348
-3% -$50.8K
PINS icon
232
Pinterest
PINS
$12.4B
$1.58M 0.07%
42,785
-4,821
-10% -$152K
IMVT icon
233
Immunovant
IMVT
$8.09B
$1.58M 0.07%
37,460
-12,409
-25% -$457K
PBR.A icon
234
Petrobras Class A
PBR.A
$107B
$1.57M 0.07%
103,026
+6,855
+7% +$98.2K
SRPT icon
235
Sarepta Therapeutics
SRPT
$1.66B
$1.57M 0.07%
16,277
+4,087
+34% +$392K
UBER icon
236
Uber
UBER
$134B
$1.56M 0.07%
+25,376
New +$1.33M
PCG icon
237
PG&E
PCG
$47.8B
$1.56M 0.07%
86,247
-789
-0.9% -$13.3K
NTLA icon
238
Intellia Therapeutics
NTLA
$1.5B
$1.55M 0.07%
50,976
+10,515
+26% +$302K
TRV icon
239
Travelers Companies
TRV
$80.8B
$1.53M 0.07%
8,053
+1,122
+16% +$194K
EDU icon
240
New Oriental
EDU
$7.84B
$1.53M 0.07%
20,870
+3,329
+19% +$231K
PTCT icon
241
PTC Therapeutics
PTCT
$6.37B
$1.53M 0.07%
55,378
+20,002
+57% +$457K
NTRA icon
242
Natera
NTRA
$37.5B
$1.53M 0.07%
24,362
-2,607
-10% -$130K
NUVL
243
DELISTED
Nuvalent
NUVL
$1.52M 0.07%
20,695
+4,479
+28% +$277K
ITUB icon
244
Itaú Unibanco
ITUB
$91.3B
$1.51M 0.06%
246,275
+16,388
+7% +$86.9K
BEAM icon
245
Beam Therapeutics
BEAM
$2.58B
$1.51M 0.06%
55,366
-1,951
-3% -$48.5K
CI icon
246
Cigna
CI
$76.6B
$1.5M 0.06%
5,002
+438
+10% +$128K
T icon
247
AT&T
T
$165B
$1.49M 0.06%
88,511
+11,226
+15% +$177K
SCHW
248
Charles Schwab
SCHW
$177B
$1.48M 0.06%
21,484
+4,496
+26% +$260K
MRTX
249
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.47M 0.06%
25,078
-15,961
-39% -$897K
IONS icon
250
Ionis Pharmaceuticals
IONS
$9.35B
$1.47M 0.06%
29,073
-6,397
-18% -$306K

Similar funds

Profund Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Profund Advisors held 1,170 positions worth $2.33B, up 29% from $1.81B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Profund Advisors deployed $261M of net new capital in Q4 2023, opening 202 new positions and adding to 753 existing holdings. Its largest new stake was Coca-Cola Europacific Partners: 35,352 shares worth $2.36M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was eBay, an estimated $1.3M trimmed.

  • Profund Advisors's largest Q4 2023 buy was Coca-Cola Europacific Partners: 35,352 shares worth $2.36M.
  • Profund Advisors added most to Broadcom in Q4 2023, an estimated $13.4M increase.
  • Profund Advisors's biggest Q4 2023 reduction was eBay, cutting an estimated $1.3M.
  • Profund Advisors fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $4.04M.
  • Profund Advisors's ten largest holdings make up 31% of its $2.33B portfolio in Q4 2023.
  • Profund Advisors opened 202 new positions and closed 43 in Q4 2023.
  • Profund Advisors's portfolio value rose 29% quarter-over-quarter to $2.33B.

Based on Profund Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.